Cape Verde vs Syria: Getting credit: Strength of legal rights index … 0-10 DB05-14 Score
Cape Verde
20
in 2013
Syria
20
in 2013
Cape Verde rank
167th
Syria rank
167th
Getting credit: Strength of legal rights index … 0-10 DB05-14 Score over time
- Cape Verde
- Syria
How they compare
Cape Verde currently reports 20 against 20 in Syria, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Cape Verde ahead.
Cape Verde ranks 167th and Syria ranks 167th of 184 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20 | 14 | 6 | Cape Verde |
| 2010s | 20 | 20 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher getting credit: strength of legal rights index (0-10) (db05-14), Cape Verde or Syria?
- Cape Verde, at 20 against 20 in Syria as of 2013.
- What is the difference in getting credit: strength of legal rights index (0-10) (db05-14) between Cape Verde and Syria?
- 0, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Syria?
- 9 years are reported by both, from 2005 to 2013.
- How do Cape Verde and Syria rank globally for getting credit: strength of legal rights index (0-10) (db05-14)?
- Cape Verde ranks 167th and Syria ranks 167th of 184 countries.
- Where does this data come from?
- The World Bank, published as Getting credit: Strength of legal rights index (0-10) (DB05-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for the strength of legal rights benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB05-14 studies.